Eshan Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 07-12-2024
- Paid Up Capital ₹ 0.20 M
as on 07-12-2024
- Company Age 34 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.60 M
as on 07-12-2024
- Satisfied Charges ₹ 0.80 M
as on 07-12-2024
- Revenue -2.92%
(FY 2016)
- Profit 132.78%
(FY 2016)
- Ebitda 27.11%
(FY 2016)
- Net Worth 6.64%
(FY 2016)
- Total Assets 14.83%
(FY 2016)
About Eshan Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹2.60 M. The company has closed loans amounting to ₹0.80 M, as per Ministry of Corporate Affairs (MCA) records.
Nehal Shah and Ronak Shah serve as directors at the Company.
- CIN/LLPIN
U24232GJ1990PTC013290
- Company No.
013290
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jan 1990
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- LocationAhmedabad, Gujarat
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Eshan Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nehal Shah  | Director | 24-Jan-1990 | Current |
| Ronak Shah | Director | 24-Jan-1990 | Current |
Financial Performance of Eshan Pharmaceuticals.
Eshan Pharmaceuticals Pvt Ltd, for the financial year ended 2016, experienced Minor drop in revenue, with a 2.92% decrease. The company also saw a substantial improvement in profitability, with a 132.78% increase in profit. The company's net worth moved up by a moderate rise of 6.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eshan Pharmaceuticals?
In 2017, Eshan Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Textile Traders Co-Operative Bank Limited Creation Date: 16 Feb 2008 | ₹1.30 M | Open |
Textile Traders Co Operative Bank Limited Creation Date: 20 Aug 2007 | ₹1.30 M | Open |
State Bank Of India Creation Date: 05 Dec 1990 | ₹0.80 M | Satisfied |
How Many Employees Work at Eshan Pharmaceuticals?
Unlock and access historical data on people associated with Eshan Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eshan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eshan Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
